BBIO: BridgeBio Pharma, Inc. Stock

by  •  • Comments Off on BBIO: BridgeBio Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6,729.33
Enterprise Value ($M) 8,046.59
Book Value ($M) -1,638.66
Book Value / Share -8.68
Price / Book -4.11
NCAV ($M) -1,825.13
NCAV / Share -9.61
Price / NCAV -3.69

Profitability (mra)
Return on Invested Capital (ROIC) -2.97
Return on Assets (ROA) -0.79
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.11
Current Ratio 5.14

Balance Sheet (mrq) ($M)
Current Assets 695.17
Assets 881.64
Liabilities 2,520.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 221.90
Operating Income -577.37
Net Income -535.76
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -520.73
Cash from Investing 60.78
Cash from Financing 748.46

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-14 13D/A KKR Genetic Disorder L.P. 7.00 -31.15
03-12 13D/A Viking Global Investors Lp 11.70 0.00
02-13 13G/A Kumar Neil 5.41 5.09
11-12 13G/A BlackRock, Inc. 6.80 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 462,082 1,915,483 24.12
2025-05-30 522,729 2,333,258 22.40
2025-05-29 520,466 2,319,188 22.44
2025-05-28 453,536 1,874,918 24.19

(click for more detail)

Similar Companies
ATRA – Atara Biotherapeutics, Inc. AVIR – Atea Pharmaceuticals, Inc.
AVXL – Anavex Life Sciences Corp. BCRX – BioCryst Pharmaceuticals, Inc.
BDTX – Black Diamond Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io